
Cregesic P 37.5mg/325mg Tablet
Marketer
Finex Healthcare Pvt Ltd
Salt Composition
Tramadol (37.5mg) + Paracetamol (325mg)
Overview Cregesic P 37.5mg/325mg Tablet
Combiflam P, a dual-action analgesic tablet (37.5mg/325mg), provides relief from moderate to severe pain. Always adhere to your physician's prescribed dosage and duration. Consumption may be independent of meals; however, if stomach discomfort occurs, take with food. Consistent dosing is crucial; discontinue only upon your doctor's instruction. Abrupt cessation is inadvisable. Potential side effects, including nausea, vomiting, dry mouth, dizziness, and constipation, are generally mild and transient. Report any rash or allergic reaction promptly. Pregnant individuals, those planning pregnancy, or breastfeeding mothers should consult their doctor before using this medication.
Primary Ingredients of Cregesic P 37.5mg/325mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Cregesic P 37.5mg/325mg Tablet
Significant to intense pain
Major Benefits of Cregesic P 37.5mg/325mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Cregesic P 37.5mg/325mg Tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistent timing is recommended for optimal results.
Common Side effects of Cregesic P 37.5mg/325mg Tablet:
- Nausea
- Vomiting
- Constipation
- Dizziness
- Dryness in mouth
- Sleepiness
- Diarrhea
- Abdominal pain
- Dyspepsia
- Flatulence
- Headache
- Trembling
- Anxiety
- Sleep disorder
- Itching
How to use Cregesic P 37.5mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Cregesic P 37.5mg/325mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. These tablets can be administered with or without food, although consistent timing is recommended.
How Cregesic P 37.5mg/325mg Tablet works:
Combiflam, a 37.5mg/325mg tablet, merges tramadol and paracetamol to effectively manage intense pain. Tramadol, an opioid analgesic, diminishes pain sensation by interrupting pain signals' journey to the brain. Paracetamol concurrently counteracts pain by inhibiting the production of specific pain-inducing chemical messengers.
SAFETY ADVICE
AlcoholUNSAFE
Combining Cregesic P 37.5mg/325mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Cregesic P 37.5mg/325mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before using this medication.
Breast feedingSAFE IF PRESCRIBED
The use of Cregesic P 37.5mg/325mg tablets while breastfeeding is likely safe. Preliminary research in humans indicates minimal risk to the infant. However, seek medical advice promptly if your baby exhibits excessive lethargy, feeding difficulties, respiratory distress, or hypotonia.
DrivingUNSAFE
Taking Cregesic P 37.5mg/325mg tablets might impair driving ability due to potential side effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Cregesic P 37.5mg/325mg tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Cregesic P 37.5mg/325mg Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Cregesic P 37.5mg/325mg Tablets are contraindicated in patients with severe or active liver disease.
What if you forget to take Cregesic P 37.5mg/325mg Tablet :
Should you forget a Cregesic P 37.5mg/325mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Cregesic P 37.5mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Pain Relievers |
